BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2020;22:391-412. [PMID: 32133741 DOI: 10.1002/ejhf.1741] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen H, Liang H, Wang T, Zhao H, Yang J, Chen X. Evaluation of left ventricular myocardial mechanics in patients with normally functioning bicuspid aortic valves: A systematic review and meta-analysis. Echocardiography 2021;38:834-43. [PMID: 33929759 DOI: 10.1111/echo.15042] [Reference Citation Analysis]
2 Smiseth OA, Baron T, Marino PN, Marwick TH, Flachskampf FA. Imaging of the left atrium: pathophysiology insights and clinical utility. Eur Heart J Cardiovasc Imaging 2021:jeab191. [PMID: 34601594 DOI: 10.1093/ehjci/jeab191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kapłon-Cieślicka A, Lund LH. Do we need a definition of acute heart failure with preserved ejection fraction? Ann Med 2021;53:1470-5. [PMID: 34431429 DOI: 10.1080/07853890.2021.1968028] [Reference Citation Analysis]
4 Sanders-van Wijk S, Barandiarán Aizpurua A, Brunner-La Rocca HP, Henkens MTHM, Weerts J, Knackstedt C, Uszko-Lencer N, Heymans S, van Empel V. The HFA-PEFF and H2 FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction. Eur J Heart Fail 2021;23:838-40. [PMID: 33012125 DOI: 10.1002/ejhf.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Smith AN, Altara R, Amin G, Habeichi NJ, Thomas DG, Jun S, Kaplan A, Booz GW, Zouein FA. Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats. J Am Heart Assoc 2022;:e026071. [PMID: 35904190 DOI: 10.1161/JAHA.122.026071] [Reference Citation Analysis]
6 Chen M, Ou L, Chen Y, Men L, Zhong X, Yang S, Luan J. Effectiveness and safety of Baduanjin exercise (BDJE) on heart failure with preserved left ventricular ejection fraction (HFpEF): A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22994. [PMID: 33181663 DOI: 10.1097/MD.0000000000022994] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Rammos A, Bechlioulis A, Kalogeras P, Tripoliti EE, Goletsis Y, Kalivi A, Blathra E, Salvo P, Trivella MG, Lomonaco T, Fuoco R, Bellagambi F, Watson CJ, Errachid A, Fotiadis DI, Michalis LK, Naka KK. Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review. Diagnostics (Basel) 2021;11:824. [PMID: 34063278 DOI: 10.3390/diagnostics11050824] [Reference Citation Analysis]
8 Androulakis E, Sohrabi C, Briasoulis A, Bakogiannis C, Saberwal B, Siasos G, Tousoulis D, Ahsan S, Papageorgiou N. Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:288. [PMID: 35053984 DOI: 10.3390/jcm11020288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huttin O, Fraser AG, Lund LH, Donal E, Linde C, Kobayashi M, Erdei T, Machu JL, Duarte K, Rossignol P, Paulus W, Zannad F, Girerd N; MEDIA and KaRen investigators. Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score. ESC Heart Fail 2021;8:1827-39. [PMID: 33656803 DOI: 10.1002/ehf2.13251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Caravita S, Iacovoni A, Senni M. The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? Eur J Heart Fail 2021. [PMID: 34231304 DOI: 10.1002/ejhf.2294] [Reference Citation Analysis]
11 Nagueh SF. Heart failure with preserved ejection fraction: insights into diagnosis and pathophysiology. Cardiovasc Res 2021;117:999-1014. [PMID: 32717061 DOI: 10.1093/cvr/cvaa228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Marcondes-Braga FG, Moura LAZ, Issa VS, Vieira JL, Rohde LE, Simões MV, Fernandes-Silva MM, Rassi S, Alves SMM, Albuquerque DC, Almeida DR, Bocchi EA, Ramires FJA, Bacal F, Rossi Neto JM, Danzmann LC, Montera MW, Oliveira Junior MT, Clausell N, Silvestre OM, Bestetti RB, Bernadez-Pereira S, Freitas AF Jr, Biolo A, Barretto ACP, Jorge AJL, Biselli B, Montenegro CEL, Santos Júnior EGD, Figueiredo EL, Fernandes F, Silveira FS, Atik FA, Brito FS, Souza GEC, Ribeiro GCA, Villacorta H, Souza Neto JD, Goldraich LA, Beck-da-Silva L, Canesin MF, Bittencourt MI, Bonatto MG, Moreira MDCV, Avila MS, Coelho Filho OR, Schwartzmann PV, Mourilhe-Rocha R, Mangini S, Ferreira SMA, Figueiredo Neto JA, Mesquita ET. Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021. Arq Bras Cardiol 2021;116:1174-212. [PMID: 34133608 DOI: 10.36660/abc.20210367] [Reference Citation Analysis]
13 Heinzel FR, Shah SJ. The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics. Herz 2022. [PMID: 35767073 DOI: 10.1007/s00059-022-05124-8] [Reference Citation Analysis]
14 Hahn VS, Knutsdottir H, Luo X, Bedi K, Margulies KB, Haldar SM, Stolina M, Yin J, Khakoo AY, Vaishnav J, Bader JS, Kass DA, Sharma K. Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction. Circulation 2021;143:120-34. [PMID: 33118835 DOI: 10.1161/CIRCULATIONAHA.120.050498] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
15 Tomasoni D, Adamo M, Metra M. April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction. Eur J Heart Fail 2022;24:593-5. [PMID: 35545950 DOI: 10.1002/ejhf.2228] [Reference Citation Analysis]
16 Forsyth F, Brimicombe J, Cheriyan J, Edwards D, Hobbs FR, Jalaludeen N, Mant J, Pilling M, Schiff R, Taylor CJ, Zaman MJ, Deaton C, Chakravorty M, Maclachlan S, Kane E, Odone J, Thorley N, Borja‐boluda S, Wellwood I, Sowden E, Blakeman T, Chew‐graham C, Hossain M, Sharpley J, Gordon B, Taffe J, Long A, Aziz A, Swayze H, Rutter H, Schramm C, Macdonald S, Papworth H, Smith J, Needs C, Cronk D, Newark C, Blake D, Brown A, Basuita A, Gayton E, Glover V, Fox R, Crawshaw J, Ashdown H, A'court C, Ayerst R, Hernandez‐diaz B, Knox K, Wooding N, Wanninayake S, Keast C, Jones A, Brown K, Gaw M, Thomas N, Dixon S, Angeleri‐rand E; OPTIMISE HFpEF investigators and collaborators. Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study. ESC Heart Failure 2021;8:4562-71. [DOI: 10.1002/ehf2.13612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kinugasa Y, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, Yamamoto K. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction. ESC Heart Fail 2021;8:2103-10. [PMID: 33734604 DOI: 10.1002/ehf2.13290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Scagliola R, Brunelli C, Balbi M. Treatment with neurohormonal inhibitors and prognostic outcome in pulmonary arterial hypertension with risk factors for left heart disease. World J Crit Care Med 2022; 11(2): 85-91 [DOI: 10.5492/wjccm.v11.i2.85] [Reference Citation Analysis]
19 Sud K, Bhatia KS, Vogel B, Bohra C, Argulian E. Prognostic significance of exercise-induced diastolic dysfunction: A systematic review. Echocardiography 2020;37:1594-602. [PMID: 32892393 DOI: 10.1111/echo.14841] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Cornuault L, Rouault P, Duplàa C, Couffinhal T, Renault M. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs? Front Physiol 2022;13:906272. [DOI: 10.3389/fphys.2022.906272] [Reference Citation Analysis]
21 Pintalhão M, Vasques-Nóvoa F, Couto-Viana B, Pimentel MJ, Neves JS, Mendonça L, Saraiva F, Lourenço AP, Ferreira G, Macedo F, Araújo JP, von Hafe P, Almeida J, Ferreira JP, Castro-Chaves P, Leite-Moreira A. Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort. Int J Cardiol 2022:S0167-5273(22)01106-8. [PMID: 35870634 DOI: 10.1016/j.ijcard.2022.07.037] [Reference Citation Analysis]
22 Sanna GD, Canonico ME, Santoro C, Esposito R, Masia SL, Galderisi M, Parodi G, Nihoyannopoulos P. Echocardiographic Longitudinal Strain Analysis in Heart Failure: Real Usefulness for Clinical Management Beyond Diagnostic Value and Prognostic Correlations? A Comprehensive Review. Curr Heart Fail Rep 2021. [PMID: 34398411 DOI: 10.1007/s11897-021-00530-1] [Reference Citation Analysis]
23 Gröger M, Scheffler JK, Schösser F, Schneider LM, Rottbauer W, Markovic S, Keßler M. Percutaneous edge-to-edge mitral valve repair for mitral regurgitation improves heart failure symptoms in heart failure with preserved ejection fraction patients. ESC Heart Fail 2021;8:5010-21. [PMID: 34498430 DOI: 10.1002/ehf2.13561] [Reference Citation Analysis]
24 Anker MS, Tschöpe C. Reply to 'Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg?'. Eur J Heart Fail 2021. [PMID: 34263996 DOI: 10.1002/ejhf.2305] [Reference Citation Analysis]
25 Fernández-bergés D, González-fernández R, Félix-redondo FJ, Arevalo Lorido J, Yeguas Rosa L, Hernández-gonzález M, Rubini A, Galán Montejano M, Gamero MC, Lozano Mera L. Evolución del perfil clínico y pronóstico de pacientes con alta hospitalaria por insuficiencia cardíaca en las dos primeras décadas del sigloxxi. El Registro INCA-Ex. Atención Primaria 2022;54:102357. [DOI: 10.1016/j.aprim.2022.102357] [Reference Citation Analysis]
26 Kadoglou NPE, Papadopoulos CH, Papadopoulos KG, Karagiannis S, Karabinos I, Loizos S, Theodosis-Georgilas A, Aggeli K, Keramida K, Klettas D, Kounas S, Makavos G, Ninios I, Ntalas G, Ikonomidis I, Sahpekidis V, Stefanidis A, Zaglavara T, Athanasopoulos G, Karatasakis G, Kyrzopoulos S, Kouris N, Patrianakos A, Rallidis L, Tsiapras D, Nihoyiannopoulos P. Updated knowledge and practical implementations of stress echocardiography in ischemic and non-ischemic cardiac diseases: an expert consensus of the Working Group of Echocardiography of the Hellenic Society of Cardiology. Hellenic J Cardiol 2021:S1109-9666(21)00148-2. [PMID: 34329766 DOI: 10.1016/j.hjc.2021.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Maffeis C, Morris DA, Belyavskiy E, Kropf M, Radhakrishnan AK, Zach V, Rozados da Conceicao C, Trippel TD, Pieske-Kraigher E, Rossi A, Pieske B, Edelmann F. Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction. ESC Heart Fail 2021;8:116-28. [PMID: 33295106 DOI: 10.1002/ehf2.13143] [Reference Citation Analysis]
28 Kameshima H, Uejima T, Fraser AG, Takahashi L, Cho J, Suzuki S, Kato Y, Yajima J, Yamashita T. A Phenotyping of Diastolic Function by Machine Learning Improves Prediction of Clinical Outcomes in Heart Failure. Front Cardiovasc Med 2021;8:755109. [PMID: 35004877 DOI: 10.3389/fcvm.2021.755109] [Reference Citation Analysis]
29 Zhang X, Zhou Y, Wei N, Shou X, Fan S, You Y, Li Y, Hu Y. A Bibliometric Analysis of Heart Failure with Preserved Ejection Fraction From 2000 to 2021. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101243] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Rosano GM, Seferovic P, Savarese G, Spoletini I, Lopatin Y, Gustafsson F, Bayes‐genis A, Jaarsma T, Abdelhamid M, Miqueo AG, Piepoli M, Tocchetti CG, Ristić AD, Jankowska E, Moura B, Hill L, Filippatos G, Metra M, Milicic D, Thum T, Chioncel O, Gal TB, Lund LH, Farmakis D, Mullens W, Adamopoulos S, Bohm M, Norhammar A, Bollmann A, Banerjee A, Maggioni AP, Voors A, Solal AC, Coats AJ. Impact analysis of heart failure across European countries: an ESC‐HFA position paper. ESC Heart Failure. [DOI: 10.1002/ehf2.14076] [Reference Citation Analysis]
31 Adams V, Wunderlich S, Mangner N, Hommel J, Esefeld K, Gielen S, Halle M, Ellingsen Ø, Van Craenenbroeck EM, Wisløff U, Pieske B, Linke A, Winzer EB. Ubiquitin-proteasome-system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF. ESC Heart Fail 2021;8:2556-68. [PMID: 33955206 DOI: 10.1002/ehf2.13405] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Moura B, Aimo A, Al-Mohammad A, Flammer A, Barberis V, Bayes-Genis A, Brunner-La Rocca HP, Fontes-Carvalho R, Grapsa J, Hülsmann M, Ibrahim N, Knackstedt C, Januzzi JL, Lapinskas T, Sarrias A, Matskeplishvili S, Meijers WC, Messroghli D, Mueller C, Pavo N, Simonavičius J, Teske AJ, van Kimmenade R, Seferovic P, Coats AJS, Emdin M, Richards AM. Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021;23:1577-96. [PMID: 34482622 DOI: 10.1002/ejhf.2339] [Reference Citation Analysis]
33 Guo K, Wu J, Kong Y, Zhou L, Li W, Fei Y, Ma J, Mi L. Label-free and noninvasive method for assessing the metabolic status in type 2 diabetic rats with myocardium diastolic dysfunction. Biomed Opt Express 2021;12:480-93. [PMID: 33659084 DOI: 10.1364/BOE.413347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Emrich IE, Scheuer AL, Rogacev KS, Mahfoud F, Wagenpfeil S, Fliser D, Schirmer SH, Böhm M, Heine GH. Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE study. Clinical Kidney Journal 2021. [DOI: 10.1093/ckj/sfab216] [Reference Citation Analysis]
35 Yano M, Nishino M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Tanaka A, Matsunaga-Lee Y, Egami Y, Shutta R, Tanouchi J, Yamada T, Yasumura Y, Tamaki S, Hayashi T, Nakagawa A, Nakagawa Y, Suna S, Nakatani D, Hikoso S, Sakata Y; Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators. High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2791-801. [PMID: 33934563 DOI: 10.1002/ehf2.13350] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Zaccone G, Tomasoni D, Italia L, Lombardi CM, Metra M. Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation. Curr Heart Fail Rep 2021;18:99-106. [PMID: 33890193 DOI: 10.1007/s11897-021-00509-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 van Veldhuisen SL, van Woerden G, Hemels MEW, America YGCJ, de Boer RA, Rienstra M, van Veldhuisen DJ, Hazebroek EJ. Preoperative cardiac screening using NT-proBNP in obese patients 50 years and older undergoing bariatric surgery: a study of 310 consecutive patients. Surg Obes Relat Dis 2021;17:64-71. [PMID: 33036941 DOI: 10.1016/j.soard.2020.08.036] [Reference Citation Analysis]
38 Hossain MZ, Chew-Graham CA, Sowden E, Blakeman T, Wellwood I, Tierney S, Deaton C. Challenges in the management of people with heart failure with preserved ejection fraction (HFpEF) in primary care: A qualitative study of general practitioner perspectives. Chronic Illn 2021;:1742395320983871. [PMID: 33401942 DOI: 10.1177/1742395320983871] [Reference Citation Analysis]
39 Palazzuoli A, Caravita S, Paolillo S, Ghio S, Tocchetti CG, Ruocco G, Correale M, Ambrosio G, Perrone Filardi P, Senni M; Italian Society of Cardiology Heart Failure Study Group. Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes. Prog Cardiovasc Dis 2021;67:89-97. [PMID: 33839166 DOI: 10.1016/j.pcad.2021.03.007] [Reference Citation Analysis]
40 Damy T, Chouihed T, Delarche N, Berrut G, Cacoub P, Henry P, Lamblin N, Andrès E, Hanon O. Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper. J Clin Med 2021;10:3519. [PMID: 34441815 DOI: 10.3390/jcm10163519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Henein MY, Lindqvist P. Diastolic function assessment by echocardiography: A practical manual for clinical use and future applications. Echocardiography 2020;37:1908-18. [PMID: 32426907 DOI: 10.1111/echo.14698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Gentile F, Ghionzoli N, Borrelli C, Vergaro G, Pastore MC, Cameli M, Emdin M, Passino C, Giannoni A. Epidemiological and clinical boundaries of heart failure with preserved ejection fraction. Eur J Prev Cardiol 2021:zwab077. [PMID: 33963839 DOI: 10.1093/eurjpc/zwab077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Dal Canto E, Remmelzwaal S, van Ballegooijen AJ, Handoko ML, Heymans S, van Empel V, Paulus WJ, Nijpels G, Elders P, Beulens JW. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction. Heart Fail Rev 2020. [PMID: 32488580 DOI: 10.1007/s10741-020-09985-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Gawałko M, Budnik M, Gorczyca I, Jelonek O, Uziębło-Życzkowska B, Maciorowska M, Wójcik M, Błaszczyk R, Tokarek T, Rajtar-Salwa R, Bil J, Wojewódzki M, Szpotowicz A, Krzciuk M, Bednarski J, Bakuła-Ostalska E, Tomaszuk-Kazberuk A, Szyszkowska A, Wełnicki M, Mamcarz A, Kapłon-Cieślicka A. Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry. J Clin Med 2021;10:1341. [PMID: 33804992 DOI: 10.3390/jcm10071341] [Reference Citation Analysis]
45 Tomasoni D, Adamo M, Metra M. June 2021 at a glance: focus on epidemiology, biomarkers and medical treatment. Eur J Heart Fail 2021;23:847-9. [PMID: 34271596 DOI: 10.1002/ejhf.1884] [Reference Citation Analysis]
46 Tschöpe C, Van Linthout S, Jäger S, Arndt R, Trippel T, Müller I, Elsanhoury A, Rutschow S, Anker SD, Schultheiss HP, Pauschinger M, Spillmann F, Pappritz K. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis. ESC Heart Fail 2020;7:2838-52. [PMID: 32662949 DOI: 10.1002/ehf2.12887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Werhahn SM, Becker C, Mende M, Haarmann H, Nolte K, Laufs U, Zeynalova S, Löffler M, Dagres N, Husser D, Dörr M, Gross S, Felix SB, Petersmann A, Herrmann-Lingen C, Binder L, Scherer M, Hasenfuß G, Pieske B, Edelmann F, Wachter R. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials. ESC Heart Fail 2021. [PMID: 34850596 DOI: 10.1002/ehf2.13703] [Reference Citation Analysis]
48 Yano M, Nishino M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Matsunaga-Lee Y, Egami Y, Tanouchi J, Yamada T, Yasumura Y, Tamaki S, Hayashi T, Nakagawa A, Nakagawa Y, Sotomi Y, Nakatani D, Hikoso S, Sakata Y; Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators. Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction. Int J Cardiol 2022;363:94-101. [PMID: 35777488 DOI: 10.1016/j.ijcard.2022.06.061] [Reference Citation Analysis]
49 Hamdani N, Costantino S, Mügge A, Lebeche D, Tschöpe C, Thum T, Paneni F. Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies. Eur Heart J 2021;42:1940-58. [PMID: 33948637 DOI: 10.1093/eurheartj/ehab197] [Reference Citation Analysis]
50 Hadzibegovic S, Lena A, Churchill TW, Ho JE, Potthoff S, Denecke C, Rösnick L, Heim KM, Kleinschmidt M, Sander LE, Witzenrath M, Suttorp N, Krannich A, Porthun J, Friede T, Butler J, Wilkenshoff U, Pieske B, Landmesser U, Anker SD, Lewis GD, Tschöpe C, Anker MS. Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail 2021. [PMID: 33932255 DOI: 10.1002/ejhf.2210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Suthahar N, Tschöpe C, de Boer RA. Being in Two Minds-The Challenge of Heart Failure with Preserved Ejection Fraction Diagnosis with a Single Biomarker. Clin Chem 2021;67:46-9. [PMID: 33257990 DOI: 10.1093/clinchem/hvaa255] [Reference Citation Analysis]
52 Shi Y, Dong G, Liu J, Shuang X, Liu C, Yang C, Qing W, Qiao W. Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis. Front Cardiovasc Med 2022;9:854501. [DOI: 10.3389/fcvm.2022.854501] [Reference Citation Analysis]
53 Zhou H, An D, Ni Z, Xu J, Zhou Y, Fang W, Lu R, Ying L, Huang J, Yao Q, Li D, Hu J, Chen B, Shen J, Jin H, Wei Y, Ouchi E, Xu L, Wu L, Mou S. Incremental diagnostic value of CMR-derived LA strain and strain rate in dialysis patients with HFpEF. European Journal of Radiology 2022;151:110285. [DOI: 10.1016/j.ejrad.2022.110285] [Reference Citation Analysis]
54 Remy KE, Verhoef PA, Malone JR, Ruppe MD, Kaselitz TB, Lodeserto F, Hirshberg EL, Slonim A, Dezfulian C. Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists. Pediatr Crit Care Med 2020;21:607-19. [PMID: 32420720 DOI: 10.1097/PCC.0000000000002429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
55 Lin J, Drapkin J, Likourezos A, Giakoumatos E, Schachter M, Sarkis JP, Shetty V, Moskovits M, Haines L, Dickman E. Emergency physician bedside echocardiographic identification of left ventricular diastolic dysfunction. Am J Emerg Med 2021;44:20-5. [PMID: 33571751 DOI: 10.1016/j.ajem.2021.01.076] [Reference Citation Analysis]
56 Jin G, Manninger M, Adelsmayr G, Schwarzl M, Alogna A, Schönleitner P, Zweiker D, Blaschke F, Sherif M, Radulovic S, Wakula P, Schauer S, Höfler G, Reiter U, Reiter G, Post H, Scherr D, Acsai K, Antoons G, Pieske B, Heinzel FR. Cellular contribution to left and right atrial dysfunction in chronic arterial hypertension in pigs. ESC Heart Fail 2021;8:151-61. [PMID: 33251761 DOI: 10.1002/ehf2.13087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Kirkman DL, Bohmke N, Billingsley HE, Carbone S. Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction. Front Endocrinol (Lausanne) 2020;11:558271. [PMID: 33117276 DOI: 10.3389/fendo.2020.558271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kobediona M, Bartunek J, Delrue L, Van Durme F, Lau CW, Moya A, Verstreken S, Heggermont W, Dierckx R, Goethals M, Vanderheyden M. Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients. Transplantation Direct 2022;8:e1336. [DOI: 10.1097/txd.0000000000001336] [Reference Citation Analysis]
59 Bingel A, Messroghli D, Weimar A, Runte K, Salcher-konrad M, Kelle S, Pieske B, Berger F, Kuehne T, Goubergrits L, Fuerstenau D, Kelm M. Hemodynamic Changes During Physiological and Pharmacological Stress Testing in Patients With Heart Failure: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2022;9:718114. [DOI: 10.3389/fcvm.2022.718114] [Reference Citation Analysis]
60 Quarta G, Gori M, Iorio A, D'Elia E, Moon JC, Iacovoni A, Burocchi S, Schelbert EB, Brambilla P, Sironi S, Caravita S, Parati G, Gavazzi A, Maisel AS, Butler J, Lam CSP, Senni M. Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities. Eur J Heart Fail 2020;22:1065-75. [PMID: 32654354 DOI: 10.1002/ejhf.1961] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
61 Bilak JM, Alam U, Miller CA, Mccann GP, Arnold JR, Kanagala P. Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis. Card Fail Rev 2022;8:e24. [DOI: 10.15420/cfr.2022.12] [Reference Citation Analysis]
62 Severino P, D’amato A, Prosperi S, Dei Cas A, Mattioli AV, Cevese A, Novo G, Prat M, Pedrinelli R, Raddino R, Gallina S, Schena F, Poggesi C, Pagliaro P, Mancone M, Fedele F; on behalf of the Italian National Institute for Cardiovascular Research (INRC). Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity? JCM 2022;11:857. [DOI: 10.3390/jcm11030857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
63 Sharp TE 3rd, Scarborough AL, Li Z, Polhemus DJ, Hidalgo HA, Schumacher JD, Matsuura TR, Jenkins JS, Kelly DP, Goodchild TT, Lefer DJ. Novel Göttingen Miniswine Model of Heart Failure With Preserved Ejection Fraction Integrating Multiple Comorbidities. JACC Basic Transl Sci 2021;6:154-70. [PMID: 33665515 DOI: 10.1016/j.jacbts.2020.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
64 Liu Z, Hu W, Zhang H, Tao H, Lei P, Liu J, Yu Y, Dong Q, Gao L, Zhang D. EAT Thickness as a Predominant Feature for Evaluating Arterial Stiffness in Patients with Heart Failure with Preserved Ejection Fraction. Diabetes Metab Syndr Obes 2022;15:1217-26. [PMID: 35494532 DOI: 10.2147/DMSO.S356001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Playford D, Strange G, Celermajer DS, Evans G, Scalia GM, Stewart S, Prior D; NEDA Investigators. Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA). Eur Heart J Cardiovasc Imaging 2021;22:505-15. [PMID: 33245344 DOI: 10.1093/ehjci/jeaa253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
66 Malik J, Valerianova A, Pesickova SS, Hruskova Z, Bednarova V, Michalek P, Polakovic V, Tesar V. CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol. J Vasc Access. [DOI: 10.1177/11297298221099843] [Reference Citation Analysis]
67 Sotomi Y, Iwakura K, Hikoso S, Inoue K, Onishi T, Okada M, Fujii K, Okamura A, Tamaki S, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Nakatani D, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigators. Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2154-64. [PMID: 33760383 DOI: 10.1002/ehf2.13302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Yano M, Nishino M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Tanaka A, Matsunaga-Lee Y, Egami Y, Shutta R, Tanouchi J, Yamada T, Yasumura Y, Tamaki S, Hayashi T, Nakagawa A, Nakagawa Y, Dohi T, Nakatani D, Hikoso S, Sakata Y; Osaka CardioVascular Conference (OCVC)-Heart Failure Investigators. Impact of admission hyperglycaemia on clinical outcomes in non-diabetic heart failure with preserved ejection fraction. ESC Heart Fail 2021. [PMID: 34190418 DOI: 10.1002/ehf2.13501] [Reference Citation Analysis]
69 Ariyaratnam JP, Lau DH, Sanders P, Kalman JM. Atrial Fibrillation and Heart Failure: Epidemiology, Pathophysiology, Prognosis, and Management. Card Electrophysiol Clin 2021;13:47-62. [PMID: 33516407 DOI: 10.1016/j.ccep.2020.11.004] [Reference Citation Analysis]
70 Sharp TE, Lefer DJ, Goodchild TT. Reply: Tolerating Large Preclinical Models of HFpEF But Without the Intolerance? JACC Basic Transl Sci 2021;6:397-9. [PMID: 33997525 DOI: 10.1016/j.jacbts.2021.03.004] [Reference Citation Analysis]
71 Paolisso P, Gallinoro E, Mileva N, Moya A, Fabbricatore D, Esposito G, De Colle C, Beles M, Spapen J, Heggermont W, Collet C, Van Camp G, Vanderheyden M, Barbato E, Bartunek J, Penicka M. Performance of non-invasive myocardial work to predict the first hospitalization for de novo heart failure with preserved ejection fraction. ESC Heart Fail 2021. [PMID: 34821061 DOI: 10.1002/ehf2.13740] [Reference Citation Analysis]
72 Kirigaya J, Iwahashi N, Abe T, Gohbara M, Hanajima Y, Horii M, Minamimoto Y, Okada K, Matsuzawa Y, Hibi K, Kosuge M, Ebina T, Tamura K, Kimura K. Influence of the cardio-ankle vascular index on chronic-phase left ventricular dysfunction after ST-segment elevation myocardial infarction. J Hypertens 2022;40:1478-86. [PMID: 35881449 DOI: 10.1097/HJH.0000000000003165] [Reference Citation Analysis]
73 Stretti L, Zippo D, Coats AJS, Anker MS, von Haehling S, Metra M, Tomasoni D. A year in heart failure: an update of recent findings. ESC Heart Fail 2021;8:4370-93. [PMID: 34918477 DOI: 10.1002/ehf2.13760] [Reference Citation Analysis]
74 Tada A, Nagai T, Omote K, Iwano H, Tsujinaga S, Kamiya K, Konishi T, Sato T, Komoriyama H, Kobayashi Y, Takenaka S, Mizuguchi Y, Sato T, Yamamoto K, Yoshikawa T, Saito Y, Anzai T. Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry. Int J Cardiol 2021:S0167-5273(21)01211-0. [PMID: 34364907 DOI: 10.1016/j.ijcard.2021.08.001] [Reference Citation Analysis]
75 Mesquita T, Zhang R, Cho JH, Zhang R, Lin YN, Sanchez L, Goldhaber JI, Yu JK, Liang JA, Liu W, Trayanova NA, Cingolani E. Mechanisms of Sinoatrial Node Dysfunction in Heart Failure With Preserved Ejection Fraction. Circulation 2022;145:45-60. [PMID: 34905696 DOI: 10.1161/CIRCULATIONAHA.121.054976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
76 Shlyakhto EV, Zvartau NE, Villevalde SV, Yakovlev AN, Soloveva AE, Fedorenko AA, Karlina VA, Avdonina NG, Endubaeva GV, Zaitsev VV, Neplyueva GA, Pavlyuk EI, Dubinina MV, Medvedeva EA, Erastov AM, Panarina SA, Solovev AE. Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia. Russ J Cardiol 2020;25:4204. [DOI: 10.15829/1560-4071-2020-4204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Fernandes-Silva MM, Mourilhe-Rocha R, Brito FS, Jorge AJL, Issa VS, Danzmann LC. Emerging Topics in Heart Failure: Heart Failure With Preserved and Mid-Range Ejection Fraction. Arq Bras Cardiol 2020;115:949-52. [PMID: 33295463 DOI: 10.36660/abc.20201105] [Reference Citation Analysis]